Exor NV

Exor announces that it has completed the sale of PartnerRe, the global reinsurer, to Covéa for a total cash consideration of $9.3 billion (approximately €8.6 billion¹). This is based on a consolidated common shareholders’ equity value of $7.3 billion as at 31 December 2021.

The acquisition of PartnerRe by Covéa reinforces PartnerRe’s development as a great company in its industry thanks to a significant increase in the scale and capital strength that membership of a larger financial institution brings, and the value that it represents for its clients.

Exor is investing €833 million to support Institut Mérieux’s growth as it continues to provide key innovative solutions in public health

Institut Mérieux (“Institut Mérieux” or “the Company”), the privately held global healthcare holding of the Mérieux family, and Exor N.V.

Following receipt of the required regulatory approvals, the investment announced on April 22 has been closed: Exor N.V. ("Exor") has today acquired a 45% shareholding in Lifenet S.r.l., an Italian company active in the healthcare sector, particularly in the management of hospitals and outpatient clinics.

The transaction entails a total investment by Exor of €67 million.

Exor N.V. (“Exor” or “the Company”), the diversified holding company controlled by the Agnelli family, announces that meeting today the Company’s Board of Directors resolved to separate the roles of Chairman and Chief Executive Officer.